BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2025 10:38:28 AM | Browse: 185 | Download: 695
Publication Name World Journal of Clinical Pediatrics
Manuscript ID 104689
Country Russia
ISSN 2219-2808 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pediatrics
Manuscript Type Retrospective Cohort Study
Article Title Analysis of fatal outcomes of patients with mucopolysaccharidosis type II according to the Russian mucopolysaccharidosis registry
Manuscript Source Invited Manuscript
All Author List Natalia Buchinskaya, Anastasia Vechkasova, Nato Vashakmadze, Leyla Namazova-Baranova, Dmitry Ivanov, Ekaterina Zakharova, Sergei Kutsev and Mikhail Kostik
ORCID
Author(s) ORCID Number
Natalia Buchinskaya http://orcid.org/0000-0002-2335-3023
Anastasia Vechkasova http://orcid.org/0009-0004-8775-9630
Nato Vashakmadze http://orcid.org/0000-0001-8320-2027
Leyla Namazova-Baranova http://orcid.org/0000-0002-2209-7531
Dmitry Ivanov http://orcid.org/0000-0002-0060-4168
Ekaterina Zakharova http://orcid.org/0000-0002-5020-1180
Sergei Kutsev http://orcid.org/0000-0002-3133-8018
Mikhail Kostik http://orcid.org/0000-0002-1180-8086
Funding Agency and Grant Number
Corresponding Author Mikhail Kostik, MD, PhD, Professor, Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Lytovskaya 2, Saint-Petersburg 194100, Sankt-Peterburg, Russia. kost-mikhail@yandex.ru
Key Words Mucopolysaccharidosis type II; IDS gene; Genotype-phenotype; Long-term outcomes; Russian Federation
Core Tip Mucopolysaccharidosis type II is a rare lysosomal storage disease characterized by the progression of multiorgan dysfunction and increased mortality rates. The assessment of the death outcomes might improve the survival of these patients. High birth weight, delayed diagnosis, delayed enzyme replacement treatment, any signs of central nervous system involvement, and progressive impossibility of independent walking were the main predictors of the fatal outcome.
Publish Date 2025-06-16 10:38
Citation

Buchinskaya N, Vechkasova A, Vashakmadze N, Namazova-Baranova L, Ivanov D, Zakharova E, Kutsev S, Kostik M. Analysis of fatal outcomes of patients with mucopolysaccharidosis type II according to the Russian mucopolysaccharidosis registry. World J Clin Pediatr 2025; 14(3): 104689

URL https://www.wjgnet.com/2219-2808/full/v14/i3/104689.htm
DOI https://dx.doi.org/10.5409/wjcp.v14.i3.104689
Full Article (PDF) WJCP-14-104689-with-cover.pdf